Rani Therapeutics Holdings Future Growth
Future criteria checks 0/6
Rani Therapeutics Holdings is forecast to grow earnings and revenue by 25.2% and 70.9% per annum respectively. EPS is expected to grow by 28.6% per annum. Return on equity is forecast to be -390.3% in 3 years.
Key information
25.2%
Earnings growth rate
28.6%
EPS growth rate
| Pharmaceuticals earnings growth | 23.5% |
| Revenue growth rate | 70.9% |
| Future return on equity | -390.3% |
| Analyst coverage | Good |
| Last updated | 16 Aug 2024 |
Recent future growth updates
Recent updates
Does Rani Therapeutics Holdings (NASDAQ:RANI) Have A Healthy Balance Sheet?
Jul 16
Is Rani Therapeutics Holdings (NASDAQ:RANI) Weighed On By Its Debt Load?
Mar 20Rani Therapeutics enters $45M loan agreement to support advancement and pipeline development
Aug 08We're Not Very Worried About Rani Therapeutics Holdings' (NASDAQ:RANI) Cash Burn Rate
Feb 13Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 20 | -27 | -26 | N/A | 7 |
| 12/31/2025 | N/A | -32 | -62 | N/A | 7 |
| 12/31/2024 | N/A | -28 | -58 | N/A | 8 |
| 6/30/2024 | N/A | -31 | -46 | -45 | N/A |
| 3/31/2024 | N/A | -33 | -49 | -48 | N/A |
| 12/31/2023 | N/A | -34 | -52 | -51 | N/A |
| 9/30/2023 | N/A | -36 | -55 | -53 | N/A |
| 6/30/2023 | N/A | -34 | -53 | -51 | N/A |
| 3/31/2023 | N/A | -33 | -51 | -49 | N/A |
| 12/31/2022 | N/A | -31 | -48 | -47 | N/A |
| 9/30/2022 | N/A | -27 | -45 | -43 | N/A |
| 6/30/2022 | N/A | -22 | -43 | -42 | N/A |
| 3/31/2022 | 2 | -15 | -38 | -38 | N/A |
| 12/31/2021 | 3 | -8 | -33 | -32 | N/A |
| 9/30/2021 | 3 | -3 | -28 | -27 | N/A |
| 6/30/2021 | 3 | N/A | -16 | -16 | N/A |
| 3/31/2021 | 1 | 5 | -13 | -13 | N/A |
| 12/31/2020 | 0 | N/A | -16 | -15 | N/A |
| 12/31/2019 | 1 | -27 | -28 | -26 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: RANI is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: RANI is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: RANI is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: RANI is forecast to have no revenue next year.
High Growth Revenue: RANI is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: RANI is forecast to be unprofitable in 3 years.